The MarketWatch News Department was not involved in the creation of this content.-- Study assessing PharmaSens all-in-one insulin patch pump provides first evidence that combining ...

Diabetes drives 25% of U.S. healthcare spend; see how CGM tech cuts finger sticks and shifts costs for patients and payers.

Global healthcare company, Abbott, announced that its continuous glucose monitoring system Lingo can now be purchased in the U.S. without a prescription. Lingo contains a biosensor and mobile app that ...

According to Future Market Insights (FMI), the shift from traditional fingerstick methods to advanced continuous glucose monitoring (CGM) systems is redefining diabetes management in both clinical and ...

The FDA is warning health providers and patients to avoid use of smart devices like watches and rings that purport to measure glucose levels without piercing the skin, the agency announced Feb. 21.

This diabetes technology offers a continuous stream of data to show a more complete picture of your blood sugars over time. This is different from a fingerstick meter that only represents that moment.

Tuesday, the FDA approved DexCom Inc’s (NASDAQ:DXCM) Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM). The Dexcom Stelo Glucose Biosensor System is ...

NEW YORK, Aug. 13, 2024 /PRNewswire/ -- The global blood glucose monitoring devices market size is estimated to grow by USD 8.70 billion from 2024-2028, according to Technavio. The market is estimated ...

Let’s dig into the relative performance of DexCom (NASDAQ:DXCM) and its peers as we unravel the now-completed Q4 patient ...

This piece of tech has taught me how to fuel better.